Systemic corticosteroids for acute gout

Cochrane Database of Systematic Reviews

Volumn , Issue 2, 2008, Pages

  Janssens, Hein J E M ^a   Lucassen, P L B J ^b   Van De Laar, F A ^b   Janssen, M ^b   Van De Lisdonk, E H ^b  

^a GP   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; CODEINE; COLCHICINE; CORTICOSTEROID; CORTICOTROPIN; DICLOFENAC; INDOMETACIN; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PLACEBO; PREDNISOLONE; TRIAMCINOLONE ACETONIDE; URICOSURIC AGENT;

ABDOMINAL PAIN; ABSENCE OF SIDE EFFECTS; CLINICAL TRIAL; COCHRANE LIBRARY; DATA BASE; DIARRHEA; DISEASE SEVERITY; DIZZINESS; DROWSINESS; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; DYSPEPSIA; DYSPNEA; EMBASE; EPIGASTRIC PAIN; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL SYMPTOM; GOUT; HUMAN; INDIGESTION; INFORMATION PROCESSING; MEDLINE; NAUSEA; OUTCOME ASSESSMENT; PAIN; RASH; REST; REVIEW; STATISTICAL ANALYSIS; THORAX PAIN; VISUAL ANALOG SCALE; VOMITING; XEROSTOMIA;

EID: 44349171281     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD005521.pub2     Document Type: Review

References (50)

1. Alloway 1993 {published data only} Alloway JA, Moriarty MJ, Hoogland YT, Nashel DJ. Comparison of triamcinolone acetonide with indomethacin in the treatment of acute gouty arthritis. The Journal of Rheumatology 1993;20(1):111-3. [MEDLINE: 51].
2. Man 2007 {published data only} Man CY, Cheung IT, Cameron PA, Rainer TH. Comparison of oral prednisolone/paracetamol and oral indomethacin/paracetamol combination therapy in the treatment of acute goutlike arthritis: a double-blind, randomized, controlled trial. Annals of Emergency Medicine 2007;49:670-7. [MEDLINE: 174].
3. Siegel 1994 {published data only} Siegel LB, Alloway JA, Nashel DJ. Comparison of adrenocorticotropic hormone and triamcinolone acetonide in the treatment of acute gouty arthritis. The Journal of Rheumatology 1994;21(7):1325-7. [MEDLINE: 52].
4. Axelrod 1988 Axelrod D, Preston S. Comparison of parenteral adrenocorticotropic hormone with oral indomethacin in the treatment of acute gout. Arthritis and Rheumatism 1988;31(6):803-5.
5. Conaghan 1994 Conaghan PG, Day RO. Risks and benefits of drugs used in the management and prevention of gout. Drug Safety: an international journal of medical toxicology and drug experience 1994;11(4):252-8. [MEDLINE: 47].
6. Groff 1990 Groff GD, Franck WA, Raddatz DA. Systemic steroid therapy for acute gout: a clinical trial and review of the literature. Seminars in Arthritis and Rheumatism 1990;19(6):329-36. [MEDLINE: 50].
7. Werlen 1996 Werlen D, Gabay C, Vischer TL. Corticosteroid therapy for the treatment of acute attacks of crystal-induced arthritis: an effective alternative to nonsteroidal antiinflammatory drugs. Revue du rhumatisme (English edition ) 1996;63(4):248-54. [MEDLINE: 53].
8. ISRCTN14648181 *Van de Lisdonk E. Randomised double blind trial of prednisone and naproxen in treatment of crystal proven acute gout. http://www.controlled-trials.com/ISRCTN14648181/14648181 2005.
9. Abbott 1988 Abbott RD, Brand FN, Kannel WB, Castelli WP. Gout and coronary heart disease: the Framingham Study. Journal of Clinical Epidemiology 1988;41:237-42.
10. Ahern 1987 Ahern MJ, Reid C, Gordon TP, McCredie M, Brooks PM, Jones M. Does colchicine work? The results of the first controlled study in acute gout. Australian and New Zealand Journal of Medicine 1987;17(3):301-4. [MEDLINE: 45].
11. Altman 1988 Altman RD, Honig S LJ, Lightfoot RW. Ketoprofen versus indomethacin in patients with acute gouty arthritis: amulticenter, double blind comparative study. The Journal of Rheumatology 1988;15: 1422-6. [MEDLINE: 101].
12. Arnold 1988 Arnold MH, Preston SJ, Watson Buchanan W. Comparison of the natural history of untreated acute gouty arthritis vs acute arthritis treated with non-steroidal-anti-inflammatory drugs. British Journal of Clinical Pharmacology 1988;26:488-9. [MEDLINE: 172].
13. Arromdee 2002 Arromdee E, Michet CJ, Crowson CS, O'Fallon WM, Gabriel SE. Epidemiology of gout: is the incidence rising?.The Journal of Rheumatology 2002;29(11):2403-6. [MEDLINE: 1].
14. Bellamy 1987 Bellamy N, Downie WW, Buchanan WW. Observations on spontaneous improvement in patients with podagra: implications for therapeutic trials of non-steroidal anti-inflammatory drugs. British Journal of Clinical Pharmacology 1987;24:33-6. [MEDLINE: 95].
15. Bieber 2004 Bieber JD, Terkeltaub RA. Gout: on the brink of novel therapeutic options for an ancient disease. Arthritis and Rheumatism 2004;50(8): 2400-14. [MEDLINE: 2].
16. Cates 2003 ChrisCates www.nntonline.com. Visual Rx -NNTCalculator.ChrisCates www.nntonline.com, 2003.
17. Cohen 1960 Cohen J. A coefficient of agreement for nominal scales. Educational and Psychological Measurement 1960;20:37-46.
18. Fam 1998 Fam AG. Gout in the elderly. Clinical presentation and treatment. Drugs & Aging 1998;13(3):229-43. [MEDLINE: 54].
19. Gotzsche 2005 Gotzsche PC, Johansen HK. Short-term low-dose corticosteroids vs placebo and nonsteroidal anti-inflammatory drugs in rheumatoid arthritis. Cochrane Database of Systematic Reviews 2005, Issue 1.[MEDLINE: 180].
20. Higgins 2002 Higgins JP, Thompson SG. Quantifying heterogeneity in a metaanalysis. Statistics in Medicine 2002;21(11):1539-58.
21. Higgins 2005 Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions 4.2.5 [updated May 2005]. www.cochrane.org/resources/handbook/hbook.htm (accessed 30 August 2005).
22. Janssens 2003 Janssens HJEM, Van de Lisdonk EH, Bor H, Van denHoogen HJM, Janssen M. Gout, just a nasty event or a cardiovascular signal? A study from primary care. Family Practice 2003;20:413-6.
23. Janssens 2006 Janssens HJEM, van de Lisdonk EH, Janssen M, van den Hoogen HJM, Verbeek ALM.Gout, not induced by diuretics? A case-control study from primary care. Annals of the Rheumatic Diseases 2006;65:1080- 3.
24. Jones 1996 Jones B, Jarvis P, Lewis JA, Ebbutt AF. Trials to assess equivalence: the importance of rigorousmethods. BMJ 1996;313:36-9. [MEDLINE: 179].
25. Kearney 2006 Kearney PM, Baigent C, Godwin J, Halls H, Emberson JR, Patrono C. Do selective cyclo-oxygenase-2 inhibitors and traditional nonsteroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials. BMJ 2006;332:1302-8. [MEDLINE: 176].
26. Kim 2003 Kim KY, Schumacher HR, Hunsche E, Wertheimer AI KS. A literature review of the epidemiology and treatment of acute gout. Clinical Therapeutics 2003;25(6):1593-617. [MEDLINE: 154].
27. Krishnan 2006 Krishnan E, Baker JF, Furst DE, Schumacher HR. Gout and the risk of acute myocardial infarction. Arthritis and Rheumatism 2006;54(8):2688-96. [MEDLINE: 160].
28. Lewis 2002 Lewis SC, Langman MJ, Laporte JR, Matthews JN, Rawlins MD, Wiholm BE. Dose-response relationships between individual nonaspirin nonsteroidal anti-inflammatory drugs (NANSAIDs) and serious upper gastrointestinal bleeding: a meta-analysis based on individual patient data. British Journal of Clinical Pharmacology 2002; 54:320-6. [MEDLINE: 155].
29. Maccagno 1991 Maccagno A, DiGiorgio E, Romanowicz A. Effectiveness of etodolac ('Lodine') compared with naproxen in patients with acute gout. Current Medical Research and Opinion 1991;12(7):423-9. [MEDLINE: 39].
30. Morris 2003 Morris I, Varughese G, Mattingly P. Colchicine in acute gout. BMJ 2003;327(7426):1275-6. [MEDLINE: 48].
31. Perez-Ruiz 2000 Perez-Ruiz F, Calabozo M, Herrero-Beites AM, Garcia-Erauskin G, Pijoan JI. Improvement of renal function in patients with chronic gout after proper control of hyperuricemia and gouty bouts. Nephron 2000;86(3):287-91. [MEDLINE: 44].
32. Petersel 2007 Petersel D, Schlesinger N. Treatment of acute gout in hospitalized patients. The Journal of Rheumatology 2007;34(7):1566-8.
33. Robinson 2002 Robinson KA, Dickersin K. Development of a highly sensitive search strategy for the retrieval of reports of controlled trials using PubMed. International Journal of Epidemiology 2002;31(1): 150-3. [MEDLINE: 36].
34. Rowe 2001 Rowe BH, Spooner C, Ducharme FM, Bretzlaff JA, Bota GW. Early emergency department treatment of acute asthma with systemic corticosteroids. Cochrane Database of Systematic Reviews 2001, Issue 1.Art. No.: CD002178. DOI:10.1002/14651858.CD002178.[MEDLINE: 177].
35. Rubin 2004 Rubin BR, Burton R, Navarra S, Antigua J, Londono J, Pryhuber KG, et al. Efficacy and safety profile of treatment with etoricoxib 120 mg once daily compared with indomethacin 50 mg three times daily in acute gout: a randomized controlled trial. Arthritis and Rheumatism 2004;50(2):598-606. [MEDLINE: 175].
36. Schlesinger 2004 Schlesinger N. Management of acute and chronic gouty arthritis: present state-of-the-art. Drugs 2004;64(21):2399- 416. [MEDLINE: 3].
37. Schlesinger 2006 Schlesinger N, Schumacher HR, Catton M, Maxwell L. Colchicine for acute gout. Cochrane Database of Systematic Reviews 2006, Issue 4.Art. No.: CD006190. DOI:10.1002/14651858.CD006190.[MEDLINE: 182].
38. Schumacher 1996 Schumacher HR. Crystal-induced arthritis: an overview. The American Journal of Medicine 1996;100(2A):46S-52S. [MEDLINE: 55].
39. Schumacher 2002 Schumacher HR Jr, Boice JA, Daikh DI, Mukhopadhyay S, Malmstrom K, Ng J, Tate GA, Molina J. Randomised double blind trial of etoricoxib and indometacin in treatment of acute gouty arthritis. BMJ 2002;324(7352):1488-92. [MEDLINE: 41].
40. Schumacher 2005 Schumacher HR Jr, Edwards LN P-RF, Becker M, Chen LX, Furst DE, Joseph-Ridge N, et al.Outcome measures for acute and chronic gout. The Journal of Rheumatology 2005;32:2452-5. [MEDLINE: 183].
41. Shrestha 1995 Shrestha M, Morgan DL, Moreden JM, Singh R, Nelson M, Hayes JE. Randomized double-blind comparison of the analgesic efficacy of intramuscular ketorolac and oral indomethacin in the treatment of acute gouty arthritis. Annals of Emergency Medicine 1995;26(6):682-6. [MEDLINE: 40].
42. Sturge 1977 Sturge RA, Scott JT, Hamilton EB, Liyanage SP, Dixon AS, Davies J, Engler C. Multicentre trial of naproxen and phenylbutazone in acute gout. Annals of the Rheumatic Diseases 1977;36(1):80-2. [MEDLINE: 38].
43. Sutaria 2006 Sutaria S, Katbamna R, Underwood M. Effectiveness of interventions for the treatment of acute and prevention of recurrent gout - a systematic review. Rheumatology (Oxford) 2006;45:1422-31. [MEDLINE: 153].
44. Terkeltaub 2003 Terkeltaub RA. Clinical practice. Gout. New England Journal of Medicine 2003;349(17):1647-55. [MEDLINE: 4].
45. Tugwell 2004 Tugwell P, Shea B, Boers M, Brooks P, Simon L, Strand V, et al.Evidence Based Rheumatology. BMJ Books, 2004.
46. Underwood 2006 Underwood M. Diagnosis and management of gout. BMJ 2006;332:1315-9. [MEDLINE: 145].
47. Van de Lisdonk 2003 Van de Lisdonk EH, Van den Bosch WJHM, Huygen FJA, Lagro-Janssen ALM. Diseases in general practice. Ziekten in de Huisartspraktijk. 4th Edition. Maarssen: Elsevier, 2003.
48. Van der Linden 2004 Van der Linden MW, Wetsert GP, De Bakker DH, Schellevis FG. Illness and disease in the community and family practice. Tweede Nationale Studie naar ziekten en verrichtingen in de huisartspraktijk. Utrecht, Bilthoven: NIVEL, Rijksinstituut voor Volksgezondheid en Milieu, 2004 (available from: http://www.nivel.nl/pdf/ ns2_rapport1.pdf ).
49. Wallace 1977 Wallace SL, Robbinson H, Masi AT, Decker JL, McArty DJ, Yü T. Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis and Rheumatism 1977;20(3): 895-900.
50. Wise 1996 Wise CM, Agudelo CA. Gouty arthritis and uric acid metabolism. Current Opinion in Rheumatology 1996;8(3):248-54. [MEDLINE: 49].